PubRank

L K Curtiss

Author PubWeight™ 130.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001 5.76
2 Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000 3.51
3 Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996 3.10
4 Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990 3.04
5 Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 1999 2.81
6 A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998 2.37
7 Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47. Arteriosclerosis 1986 1.81
8 Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem 1982 1.80
9 Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol 1999 1.78
10 Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001 1.73
11 Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest 1995 1.72
12 Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996 1.65
13 Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J Clin Invest 1987 1.56
14 Parallel expression of the MB19 genetic polymorphism in apoprotein B-100 and apoprotein B-48. Evidence that both apoproteins are products of the same gene. J Biol Chem 1986 1.54
15 Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol 1976 1.48
16 Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res 1984 1.39
17 Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 1981 1.34
18 Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 2006 1.32
19 The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem 2001 1.30
20 Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity. J Exp Med 1984 1.23
21 A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J Biol Chem 1998 1.22
22 High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 1999 1.21
23 Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 1994 1.20
24 Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995 1.20
25 A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins. J Clin Invest 1983 1.20
26 Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem 1986 1.19
27 Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. Proc Natl Acad Sci U S A 1986 1.18
28 Chemokines and atherosclerosis. Curr Opin Lipidol 1998 1.16
29 Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J Clin Invest 1987 1.16
30 Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 2000 1.13
31 Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase. J Biol Chem 2001 1.12
32 Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. J Immunol 1977 1.12
33 Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest 1991 1.12
34 Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals. J Clin Invest 1984 1.11
35 Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. J Clin Invest 1997 1.10
36 Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. J Biol Chem 1982 1.09
37 Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res 1997 1.07
38 Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb 1993 1.06
39 In vivo suppression of the primary immune response by a species of low density serum lipoprotein. J Immunol 1977 1.03
40 Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 1999 1.02
41 A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. J Immunol 1985 1.01
42 Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J Immunol 1986 1.01
43 Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. J Clin Invest 1981 1.01
44 Apolipoprotein B allotypes MB19(1) and MB19(2) in subjects with coronary artery disease and hypercholesterolemia. Arteriosclerosis 1987 1.01
45 THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets. J Lipid Res 1991 1.00
46 Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem 1994 0.99
47 Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice. J Lipid Res 2000 0.98
48 Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. J Lipid Res 1995 0.97
49 Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy. J Biol Chem 1991 0.97
50 Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia. J Lipid Res 1996 0.97
51 Toll-like receptors in atherosclerosis. Biochem Soc Trans 2007 0.96
52 Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies. J Biol Chem 1985 0.96
53 ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages. Arterioscler Thromb Vasc Biol 1999 0.96
54 Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J Clin Invest 1993 0.95
55 Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein. J Clin Invest 1979 0.95
56 ApoE in atherosclerosis : a protein with multiple hats. Arterioscler Thromb Vasc Biol 2000 0.95
57 The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia 2007 0.94
58 Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb 1994 0.94
59 Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997 0.94
60 Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J Lipid Res 1997 0.94
61 Anti-apoprotein B monoclonal antibodies detect human low density lipoprotein polymorphism. J Biol Chem 1984 0.93
62 Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. J Clin Invest 1978 0.93
63 Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I. J Lipid Res 2005 0.92
64 Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor. J Biol Chem 1987 0.92
65 Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus. J Clin Invest 1981 0.90
66 New mechanism for foam cell generation in atherosclerotic lesions. J Clin Invest 1987 0.89
67 Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. J Biol Chem 1991 0.89
68 Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding. J Biol Chem 1998 0.89
69 An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo. J Clin Invest 1998 0.88
70 Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. FEBS Lett 1993 0.87
71 13C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain. J Biol Chem 1991 0.87
72 The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. J Biol Chem 1998 0.87
73 Interaction of plasma lipoproteins with human platelets. Blood 1984 0.86
74 Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids. J Immunol 1981 0.86
75 Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering. Biochemistry 1995 0.86
76 Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985 0.86
77 A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. J Lipid Res 1997 0.85
78 Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice. J Lipid Res 1999 0.85
79 Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor. J Lipid Res 1995 0.85
80 Interaction between ApoB and hepatic lipase mediates the uptake of ApoB-containing lipoproteins. J Biol Chem 1998 0.85
81 Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide. J Clin Invest 1985 0.84
82 Platelet-enhanced apolipoprotein E production by human macrophages: a possible role in atherosclerosis. J Lipid Res 1988 0.84
83 Interaction of Lp(a) with plasminogen binding sites on cells. Thromb Haemost 1995 0.84
84 Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. J Biol Chem 1988 0.84
85 Localization of coliphage MS2 A-protein. J Virol 1974 0.83
86 Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J Biol Chem 1991 0.83
87 Influence of the immunoregulatory serum lipoprotein LDL-In on the in vivo proliferation and differentiation of antigen-binding and antibody-secreting lymphocytes during a primary immune response. Cell Immunol 1980 0.83
88 Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q. J Immunol 1986 0.83
89 An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells. J Biol Chem 1994 0.82
90 Stoichiometric binding of apolipoprotein B-specific monoclonal antibodies to low density lipoproteins. J Biol Chem 1985 0.82
91 Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis. Am J Pathol 1996 0.82
92 Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay. J Lipid Res 1988 0.82
93 Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice. Biochim Biophys Acta 1997 0.82
94 Low density lipoprotein inhibits the physical interaction of phlogistic crystals and inflammatory cells. Arthritis Rheum 1986 0.82
95 Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. J Lipid Res 1994 0.82
96 Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. J Biol Chem 1994 0.82
97 The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content. J Immunol 1981 0.81
98 Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase. J Clin Invest 1992 0.81
99 Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation. Biochemistry 1999 0.80
100 Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation. J Immunol 1984 0.80
101 Apolipoprotein B mediates the capacity of low density lipoprotein to suppress neutrophil stimulation by particulates. J Biol Chem 1986 0.80
102 Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. Arterioscler Thromb 1994 0.80
103 A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J Biol Chem 1991 0.79
104 Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J Biol Chem 1994 0.79
105 Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. Cancer Res 1981 0.79
106 Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. J Lipid Res 1989 0.79
107 Detection of two apolipoprotein B species (apoBc and apoBg) by a monoclonal antibody. Atherosclerosis 1987 0.78
108 An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17alpha-hydroxylase, C17-20 lyase. J Lipid Res 1998 0.78
109 Purification and characterization of coliphage MS2 hapten conjugates. J Immunol 1973 0.78
110 Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In. J Immunol 1980 0.77
111 Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments. J Immunol 1987 0.77
112 Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules. Thromb Haemost 1999 0.76
113 Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid. Biochemistry 1998 0.76
114 Activation of C1 by monoclonal antibodies directed against C1q. Biochem Biophys Res Commun 1985 0.76
115 Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B. J Biol Chem 1995 0.76
116 Monoclonal antibody detects Ag polymorphism of apolipoprotein B. FEBS Lett 1986 0.76
117 Ag(c): recognition by a monoclonal antibody. Arteriosclerosis 1986 0.76
118 Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies. J Lipid Res 1997 0.75
119 International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. J Automat Chem 1990 0.75
120 A method for localizing the early products of nonenzymatic glycosylation in fixed tissue. J Invest Dermatol 1989 0.75
121 Effect of long chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine on the interaction with recombinant high density lipoprotein apolipoprotein A-I. J Lipid Res 1998 0.75
122 Immunochemical isolation and identification of glucosylated apolipoproteins. Methods Enzymol 1986 0.75
123 The influence of antigen on a model for analysis of multiple coordinate events associated with the primary immune response. Immunopharmacology 1979 0.75
124 Feasibility of an immunoassay for mevalonolactone. Bioorg Med Chem 1997 0.75
125 International Federation of Clinical Chemistry (IFCC) Scientific Division. Committee on Apolipoproteins, Working Group on Antibody Reagents. Selection and characterization of monoclonal antibodies for measuring plasma levels of apolipoproteins A-I and B. Ann Biol Clin (Paris) 1990 0.75
126 The use of monoclonal antibodies to detect genetic polymorphism: application to apolipoprotein B. Prog Clin Biol Res 1985 0.75
127 Glycosaminoglycans alter the capacity of low density lipoprotein to bind to monosodium urate crystals. J Rheumatol 1990 0.75
128 The relative immunodominance of haptenic determinants on a complex hapten phage conjugate. Immunochemistry 1975 0.75
129 Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E. J Lipid Res 1994 0.75
130 Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. J Lipid Res 1994 0.75